|By PR Newswire||
|September 2, 2014 03:00 AM EDT||
-- Goodwin Biotechnology pioneered best-in-class practices for the development of complex Biopharmaceuticals and Antibody Drug Conjugates (ADCs)
LONDON, Sept. 2, 2014 /PRNewswire/ -- Based on its recent analysis of the mammalian contract manufacturing services market, Frost & Sullivan recognises Goodwin Biotechnology with the 2014 Global Frost & Sullivan Award for Customer Value Leadership. Goodwin Biotechnology's reputation as one of the most trusted providers of mammalian contract manufacturing and development services has been built on more than 20 years of experience in the bioprocess development and cGMP manufacturing of mammalian cell culture-derived monoclonal antibodies (mAbs), vaccines, and recombinant proteins, and more than 10 years pioneering the field of bioconjugation.
Goodwin Biotechnology championed the concept of 'full integration' in the biopharmaceutical contract manufacturing space. It is a one-stop shop, offering its partners a comprehensive range of services from cell line development and proof-of-concept projects to bioprocess development and the manufacture of material for preclinical / Tox studies as well as early to late phase clinical trials.
Goodwin Biotechnology strives to be a highly flexible partner with its clients by finding customized solutions for the distinctive needs of every project and ensuring smooth implementation all throughout the lifecycle of an engagement. Furthermore, it has enhanced its brand value on a global basis by maintaining high levels of transparency and responsiveness while focusing on quality, and working within budgets and timelines.
The core services offered by Goodwin Biotechnology include cell line development through collaborations, cell culture and purification process development, cell banking, process scale-up, engineering runs for toxicology study materials, and strict adherence to current good manufacturing practices (cGMP) for manufacturing and providing Fill / Finish services for biopharmaceutical candidates used in human clinical trials. The company has also established best-in-class processes for the production of antibody drug conjugates (ADCs), cytotoxic ADCs (CADCs), antibody-chelator conjugates (for radioimmunoconjugates) and other bioconjugates.
"These core services are fully complemented and enhanced by the company's analytical and formulation development capabilities as well as its quality assurance, quality control, regulatory and project management capabilities," said Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram. "The complete and fully-integrated services offered by Goodwin Biotechnology reduce the supply chain complexities and timeline for clients to efficiently meet their preclinical and clinical needs."
"We at Goodwin Biotechnology are honored to be recognized for such a prestigious award, which showcases our orientation towards providing our clients with the best overall value proposition," noted Karl Pinto, CEO of Goodwin Biotechnology. "It is a testament to the company's rich and distinguished history, coupled with its innovative, state-of-the-art technologies, and highly skilled scientists that enables us to meet the expectations of customers across the globe and at various stages of their respective product development cycles. Having addressed challenges pertaining to the manufacturing of complex biological molecules, such as monoclonal antibodies, recombinant therapeutic proteins, vaccines and cytotoxic ADCs (CADCs), Goodwin Biotechnology helps our clients formulate a strategic approach with particular emphasis on critical protein product characterization, process development, and cGMP manufacturing for regulatory compliance."
"Goodwin Biotechnology's time-tested expertise with various host cell types and process optimisation techniques enables seamless technology transfers between R&D and GMP manufacturing for clinical studies," added Chidambaram. "It is one of the few contract manufacturing organisations to have installed capabilities for a number of robust and reproducible cell cultivation technologies, including disposable bioreactors such as, WAVE, perfusion, and stainless steel tank bioreactors."
At the start of every project, Goodwin Biotechnology focuses on optimising and refining the processes to maximize productivity and ensure seamless scale up. Towards that end, the company has hands-on experience in several chromatographic techniques including affinity, ion exchange, hydrophobic interaction, mixed mode, and size-exclusion chromatography. In addition, its ultrafiltration/diafiltration (UF/DF) processes use tangential flow filtration (TFF) technologies in both flat-plate and hollow-fiber formats.
Goodwin Biotechnology also addresses complex issues associated with antibody drug conjugates, including linker design, drug payload selection, and antibody stability in the production of multi-gram lots of conjugated antibodies used globally in clinical trials. Apart from its rich and varied expertise in protein modification through chemical conjugation and enzymatic digestion methods, Goodwin Biotechnology also offers unique specialties such as the production of Fab and F(ab')2 fragments and their subsequent purification as per client specifications.
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognises the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and, ultimately, customer base expansion.
Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Goodwin Biotechnology
Goodwin Biotechnology is a world-class CMO that offers a Single Source Solution™ through partnerships with clients for cell line development or exploratory proof of concept projects through process development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and Antibody Drug Conjugates (ADCs) and other Biologic Drug Conjugates for early and late stage clinical trials. By working with Goodwin Biotechnology, our clients can enhance the value of their product candidates with clear development and manufacturing strategies as well as a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely, and cGMP compliant manner to enhance patients' lives. With over 20 years of experience as an independent contract manufacturer, Goodwin Biotechnology has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established and multi-national biopharmaceutical companies. Additional information may be found at http://www.GoodwinBio.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Frost & Sullivan
Goodwin Biotechnology, Inc.
Best Practices, Frost & Sullivan
Manager of Business Development
P: +44 (0) 207 915 7867
Why do your mobile transformations need to happen today? Mobile is the strategy that enterprise transformation centers on to drive customer engagement. In his general session at @ThingsExpo, Roger Woods, Director, Mobile Product & Strategy – Adobe Marketing Cloud, covered key IoT and mobile trends that are forcing mobile transformation, key components of a solid mobile strategy and explored how brands are effectively driving mobile change throughout the enterprise.
Sep. 29, 2016 11:30 AM EDT Reads: 2,122
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
Sep. 29, 2016 11:15 AM EDT Reads: 5,126
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
Sep. 29, 2016 11:00 AM EDT Reads: 291
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lea...
Sep. 29, 2016 11:00 AM EDT Reads: 388
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Sep. 29, 2016 11:00 AM EDT Reads: 3,503
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
Sep. 29, 2016 11:00 AM EDT Reads: 4,164
The Jevons Paradox suggests that when technological advances increase efficiency of a resource, it results in an overall increase in consumption. Writing on the increased use of coal as a result of technological improvements, 19th-century economist William Stanley Jevons found that these improvements led to the development of new ways to utilize coal. In his session at 19th Cloud Expo, Mark Thiele, Chief Strategy Officer for Apcera, will compare the Jevons Paradox to modern-day enterprise IT, e...
Sep. 29, 2016 11:00 AM EDT Reads: 2,389
What are the new priorities for the connected business? First: businesses need to think differently about the types of connections they will need to make – these span well beyond the traditional app to app into more modern forms of integration including SaaS integrations, mobile integrations, APIs, device integration and Big Data integration. It’s important these are unified together vs. doing them all piecemeal. Second, these types of connections need to be simple to design, adapt and configure...
Sep. 29, 2016 10:45 AM EDT Reads: 438
Let’s face it, embracing new storage technologies, capabilities and upgrading to new hardware often adds complexity and increases costs. In his session at 18th Cloud Expo, Seth Oxenhorn, Vice President of Business Development & Alliances at FalconStor, discussed how a truly heterogeneous software-defined storage approach can add value to legacy platforms and heterogeneous environments. The result reduces complexity, significantly lowers cost, and provides IT organizations with improved efficienc...
Sep. 29, 2016 10:45 AM EDT Reads: 3,580
SYS-CON Events announced today that CDS Global Cloud, an Infrastructure as a Service provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. CDS Global Cloud is an IaaS (Infrastructure as a Service) provider specializing in solutions for e-commerce, internet gaming, online education and other internet applications. With a growing number of data centers and network points around the world, ...
Sep. 29, 2016 10:30 AM EDT Reads: 2,977
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.
Sep. 29, 2016 10:30 AM EDT Reads: 2,894
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Sep. 29, 2016 10:30 AM EDT Reads: 4,441
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
Sep. 29, 2016 10:30 AM EDT Reads: 1,235
There are several IoTs: the Industrial Internet, Consumer Wearables, Wearables and Healthcare, Supply Chains, and the movement toward Smart Grids, Cities, Regions, and Nations. There are competing communications standards every step of the way, a bewildering array of sensors and devices, and an entire world of competing data analytics platforms. To some this appears to be chaos. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, Bradley Holt, Developer Advocate a...
Sep. 29, 2016 10:15 AM EDT Reads: 2,366
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Sep. 29, 2016 10:15 AM EDT Reads: 3,297